Comprehensive analyses reveal TKI-induced remodeling of the tumor immune microenvironment in EGFR/ALK-positive non-small-cell lung cancer

Tyrosine kinase inhibitors (TKI) play a pivotal role in the treatment of non-small-cell lung cancer (NSCLC) with mutations in epidermal growth factor receptor (EGFR) and rearrangements in anaplastic lymphoma kinase (ALK). However, the influences of TKIs on the tumor immune microenvironment (TIM), es...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yisheng, Wang, Yuanyuan, Zeng, Dongqiang, Zhi, Shimeng, Shu, Tingting, Huang, Na, Zheng, Siting, Wu, Jianhua, Liu, Yantan, Huang, Genjie, Xue, Yichen, Bin, Jianping, Liao, Yulin, Shi, Min, Liao, Wangjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288040/
https://www.ncbi.nlm.nih.gov/pubmed/34345533
http://dx.doi.org/10.1080/2162402X.2021.1951019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288040/
https://www.ncbi.nlm.nih.gov/pubmed/34345533
http://dx.doi.org/10.1080/2162402X.2021.1951019

Ejemplares similares